中西整合治療模式減少血液透析病患住院醫療費用

Integrated Chinese and Western Medicine Treatment Model is Associated with Reduced Hospitalization Costs for Hemodialysis patients

廖殷梓(Liao Yin-Tzu)；林軒名(Lin Hsuan-Ming)；魏照軒(Wei Chao-Hsuang)；許雅賢(Hsu Ya-Hsien)；蘇玲雅(Su Ling-Ya)；呂育雯(Lu Yu-wen)

中西整合治療 ； 血液透析 ； 醫療費用 ； Integrated Chinese and Western medicine ； hemodialysis ； medical expenses

中西整合醫學雜誌

23卷2期（2021 / 12 / 31）

12 - 21

繁體中文

台灣慢性腎臟病及末期腎臟病的盛行率和發生率高居世界第一，而透析治療所花費的醫療費用也十分驚人，如何兼顧療效與降低醫療成本是很重要的議題。對於血液透析病人，過去的研究大多顯示中西整合治療的療效，缺少關於醫療費用支出的討論。因此本研究著重在分析中西整合治療後是否能減少醫療費用的支出。方法：本研究為回溯性研究，納入2014年1月至2018年6月臺南市立安南醫院接受中西整合治療的血液透析患者。比較中西整合治療病患在接受治療前三個月與接受治療後三個月的就醫次數與醫療費用的差異。結果：納入36位受試者。中西醫整合治療後與治療前相比，住院次數與住院醫療費用下降，不過急診次數與門急診醫療費用上升，而總醫療費用則是下降。住院醫療費用的降低有達到統計學上的意義（p=0.005）。結論：本研究是第一篇探討血液透析病患經中西整合治療後是否能減少醫療費用的支出，結果顯示中西整合治療後住院醫療費用降低有達到統計學意義，可惜的是總醫療費用雖然有下降，但無達到統計學差異，有可能是追蹤的時間太短導致效益無法顯現。從本研究可知，對於血液透析病患建議可採用中西整合治療模式以降低醫療成本的支出。

Background: The prevalence and incidence of chronic kidney disease and end-stage renal disease in Taiwan are the highest globally, so the medical costs of dialysis treatment are very staggering. It is a critical issue to reduce medical costs. Most of the past studies had shown the efficacy of integrated Chinese and Western treatment for hemodialysis patients, and there was a lack of discussion on medical expenses. Therefore, this study aims to analyze whether Chinese and Western medicine's integrated treatment can reduce medical costs. Method: A retrospective study was conducted at An-Nan hospital in Taiwan. Hemodialysis patients who received integrated Chinese and Western treatment were included from January 2014 to June 2018. We compared the differences in hospitalization, emergent unit visits, and patients' medical expenses with Chinese and Western integrated treatment three months before and after treatment. Result: 36 patients were included. After the integrated treatment of Chinese and Western medicine therapy, hospitalization costs reached a statistically significant reduction compared with before the treatment (p=0.005). Conclusion: This study is the first to explore whether integrated Chinese and Western treatment in hemodialysis patients were associated with reducingical expenses. After the statistical analyisis, the hospitalization medical expenses after treatment was signisignificantlyeased. However, the total expenses decreased no-significantly. It ma bmayrelated to shothe rt duration of this study. Therefore, it is recommended for hemodialysis patients to adopt an integrated Chinese and Western treatment model to reduce medical costs.

1. (2018)。以醫療失效模式與效應分析改善中醫毫針刺出入針數不符之風險。J Chin Med，29(2)，84-100。
   連結：
2. Adams, S v.,Rivara, M,Streja, E,Cheung, AK,Arah, OA,Kalantar-Zadeh, K,Mehrotra, R(2017).Sex Differences in Hospitalizations with Maintenance Hemodialysis.Journal of the American Society of Nephrology,28(9),2721-2728.
3. Alem, AM,Sherrard, DJ,Gillen, DL,Weiss, NS,Beresford, SA,Heckbert, SR,Wong, C,Stehman-Breen, C(2000).Increased risk of hip fracture among patients with end-stage renal disease.Kidney International,58(1),396-399.
4. Bergwitz, C,Jüppner, H(2010).Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.Annual Review of Medicine,61,91-104.
5. Hsieh, CF,Huang, SL,Chen, CL,Chen, WT,Chang, HC,Yang, CC(2014).Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease: Results from a population-based follow-up study.BMJ Open,4(2),e004033.
6. Huang, KC,Su, YC,Sun, MF,Huang, ST(2018).Chinese herbal medicine improves the long-term survival rate of patients with chronic kidney disease in Taiwan: A nationwide retrospective population-based cohort study.Frontiers in Pharmacology,9,1-10.
7. Kim, KH,Lee, MS,Choi, SM,Ernst, E(2010).Acupuncture for treating uremic pruritus in patients with end-stage renal disease: A systematic review.Journal of Pain and Symptom Management,40,117-125.
8. Liao, PF,Wang, YT,Wang, YH,Chiou, JY,Wei, JCC(2020).Traditional Chinese medicine use may reduce medical utility in patients with asthma: a nationwide population-based retrospective cohort study.QJM: An International Journal of Medicine
9. Lin, MY,Cheng, LJ,Chiu, YW,Hsieh, HM,Wu, PH,Lin, YT,Wang, SL,Jian, FX,Hsu, CC,Yang, SA,Lee, HL,Hwang, SJ(2018).Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population-based study.PLoS ONE,13(6),e0198387.
10. Moe, SM,Sprague, SM(2011).Chronic Kidney Disease-Mineral Bone Disorder.
11. Palmer, SC,Hayen, A,Macaskill, P,Pellegrini, F,Craig, JC,Elder, GJ,Strippoli, GFM(2011).Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease a systematic review and meta-analysis.JAMA-Journal of the American Medical Association,305,1119-1127.
12. Su, SY,Muo, CH,Morisky, DE(2015).Use of Chinese medicine correlates negatively with the consumption of conventional medicine and medical cost in patients with uterine fibroids: A population-based retrospective cohort study in Taiwan.BMC Complementary and Alternative Medicine,15(1),129.
13. Taiwan Society of Nephrology. Annual Report on Kidney Disease in Taiwan 2017. 2018
14. Ur Rehman, I,Chohan, TA,Bukhsh, A,Khan, TM(2019).Impact of pruritus on sleep quality of hemodialysis patients: A systematic review and meta-analysis.Medicina,55
15. 宋煒,宋維明(2000)。慢性腎功能衰竭血液透析併發症的中醫治療。河北中醫藥學報，15(1)，11-12。
16. 宋維明,胡蜀賓(2008)。中醫防治慢性腎功能衰竭血液透析併發症體會。中國中醫藥資訊雜誌，15(10)，77-77。
17. 林軒名,陳淑嬌,蘇麗惠,何宗融,廖殷梓(2003)。中西醫結合治療慢性腎臟病對於腎絲球過濾率的影響。中醫內科醫學雜誌，15(2)，11-26。
18. 林軒名,陳淑嬌,蘇麗惠,何宗融,廖殷梓(2013)。以科學中藥介入血液透析患者的安全性研究 : 以肝腎功能和血中電解質濃度分析。中醫內科醫學雜誌，13(2)，1-8。
19. 陳岩,李可今(2004)。中醫中藥防治慢性腎功能衰竭患者透析併發症。河北中醫，26(12)，917-918。